2020-12-29,VBL Therapeutics Announces First Patient in Europe in the OVAL Trial
2020-12-07,VBL Therapeutics Announces Insider Buying
2020-11-18,Vascular Biogenics Ltd. (NASDAQ:VBLT) Analysts Just Slashed Next Year's Revenue Estimates By 16%
2020-11-16,"Vascular Biogenics (VBLT) Reports Q3 Loss, Tops Revenue Estimates"
2020-11-16,Vascular Biogenics: Q3 Earnings Insights
2020-11-16,VBL Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
2020-11-16,Vascular Biogenics Ltd. to Host Earnings Call
2020-11-16,How Much Is Vascular Biogenics Ltd. (NASDAQ:VBLT) Paying Its CEO?
2020-11-15,"The Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The Markets"
2020-11-13,Earnings Outlook For Vascular Biogenics
2020-11-05,VBL Therapeutics to Present at the H.C. Wainwright 6th Annual Israel Conference
2020-11-02,VBL Therapeutics to Report Third Quarter 2020 Financial Results on November 16
2020-10-15,"VBL Therapeutics Announces Additional New European Patent in the MOSPD2 Platform Technology, This Time for Treatment of Cancer"
2020-10-13,VBL Therapeutics Announces Appointment of Marc Kozin as Vice Chairman of Board of Directors
2020-10-12,Newly Granted European Patent Protects VBL Therapeutics' Anti-MOSPD2 Antibodies for Inflammation Until at least July 2036
2020-09-29,VBL Therapeutics to Present at the Chardan 4th Annual Genetic Medicines Conference
2020-09-21,VBL Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
2020-09-17,Who Has Been Buying Vascular Biogenics Ltd. (NASDAQ:VBLT) Shares?
2020-09-15,VBL Therapeutics to Provide an Update on the OVAL Study Today at the H. C. Wainwright 22nd Annual Global Investment Conference
2020-09-11,VBL Presents Human Proof-of-Concept Data That Show the Potential of its Novel anti-MOSPD2 Monoclonal Antibodies for Multiple Sclerosis at the MS Virtual 2020 Meeting
2020-09-10,VBL Therapeutics Announces Enrollment of the First Patients in the Phase 2 Clinical Trial of VB-111 in Metastatic Colorectal Cancer
2020-09-08,VBL Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA Regarding Proposed Clinical Development of VB-601
2020-08-13,"Vascular Biogenics (VBLT) Reports Q2 Loss, Misses Revenue Estimates"
2020-08-13,Vascular Biogenics: Q2 Earnings Insights
2020-08-13,VBL Therapeutics Announces Second Quarter 2020 Financial Results and Provides Corporate Update
2020-08-12,VBL Therapeutics Announces Second Successful Pre-planned Interim Analysis with a Positive Data Safety Monitoring Committee Review Looking at OS - the Primary Endpoint of the OVAL Phase 3 Potential Registration Study of VB-111 in Ovarian Cancer
2020-08-06,Earnings Preview: Vascular Biogenics (VBLT) Q2 Earnings Expected to Decline
2020-08-03,VBL Therapeutics to Report Second Quarter 2020 Financial Results on August 13
2020-07-15,"MORNING BID-Fog, stall ... rally"
2020-06-25,Growth Investors: Industry Analysts Just Upgraded Their Vascular Biogenics Ltd. (NASDAQ:VBLT) Revenue Forecasts By 24%
2020-06-22,VBL Therapeutics Presents MOSPD2 Bi-Specific Antibody Activity and Potential Survival Benefit for Solid Tumors in Late Breaking Research Session of the AACR Virtual Annual Meeting
2020-06-04,VBL Presents New Data on the Potential of its Novel anti-MOSPD2 Monoclonal Antibodies for Rheumatoid Arthritis at the EULAR 2020 Congress
2020-06-01,"VBL Presents Positive Interim Data from the OVAL Phase 3 Pivotal Study in Ovarian Cancer at the ASCO20 Annual Meeting, Showing 58% or Higher Objective Response Rate"
2020-05-28,3 Strong Buy Penny Stocks That Offer Massive Potential Gains
2020-05-18,Earnings Update: Vascular Biogenics Ltd. (NASDAQ:VBLT) Just Reported And Analysts Are Boosting Their Estimates
2020-05-18,VBL Therapeutics to Present New Data on Its MOSPD2 Bispecific Antibody Program for Solid Tumors in Late Breaking Research Session of the AACR Virtual Annual Meeting
2020-05-15,This Just In: Analysts Are Boosting Their Vascular Biogenics Ltd. (NASDAQ:VBLT) Outlook for This Year
2020-05-14,Recap: Vascular Biogenics Q1 Earnings
2020-05-14,"Vascular Biogenics (VBLT) Reports Q1 Loss, Tops Revenue Estimates"
2020-05-14,VBL Therapeutics Announces First Quarter 2020 Financial Results and Provides Corporate Update
2020-05-13,VBL Therapeutics Closes $8.1 Million Registered Direct Offering to Key Current Shareholders Priced At-the-Market under Nasdaq Rules
2020-05-12,"VBL Therapeutics Closes $10.0 Million Registered Direct Offering and Announces $8.1 Million Registered Direct Offering to Key Current Shareholders, Each Priced At-the-Market under Nasdaq Rules"
2020-05-07,Earnings Preview: Vascular Biogenics (VBLT) Q1 Earnings Expected to Decline
2020-05-07,VBL Therapeutics Announces $10.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
2020-05-06,VBL Presents New Data on MOSPD2 Antibodies as Potential Treatment for NASH and Colitis at DDW
2020-05-05,"Introducing Vascular Biogenics (NASDAQ:VBLT), The Stock That Tanked 77%"
2020-05-04,VBL Therapeutics to Report First Quarter 2020 Financial Results on May 14
2020-05-04,VBL First-in-class MOSPD2 Antibodies Show Potential for Treatment for CNS Inflammation
2020-04-21,VBL Therapeutics Awarded 3.2 Million NIS Non-Dilutive Grant by the Israel Innovation Authority for VB-111
2020-04-06,VBL Therapeutics Announces New Milestone Event in the VB-201 Collaboration for Veterinary Use
2020-04-02,"Following Positive Interim Analysis, VB-111 Global Study in Ovarian Cancer to Extend to Japan via Collaboration with NanoCarrier"
2020-03-26,Edited Transcript of VBLT earnings conference call or presentation 19-Mar-20 12:30pm GMT
2020-03-26,VBL Therapeutics Announces Positive Outcome of the Interim Analysis in the OVAL Phase 3 Ovarian Cancer Pivotal Study
2020-03-21,Earnings Update: Vascular Biogenics Ltd. (NASDAQ:VBLT) Just Reported And Analysts Are Trimming Their Forecasts
2020-03-19,Vascular Biogenics: Q4 Earnings Insights
2020-03-19,"Vascular Biogenics (VBLT) Reports Q4 Loss, Lags Revenue Estimates"
2020-03-19,"VBL Therapeutics Announces Year Ended December 31, 2019 Financial Results and Provides Corporate Update"
2020-03-19,Vascular Biogenics Ltd. to Host Earnings Call
2020-03-12,Analysts Estimate Vascular Biogenics (VBLT) to Report a Decline in Earnings: What to Look Out for
2020-03-02,VBL Therapeutics to Report Fourth Quarter 2019 Financial Results on March 19
2020-02-20,"VBL Therapeutics Announces the Launch of a New Clinical Trial of VB-111 Combined with the Checkpoint Inhibitor, Nivolumab, in Metastatic Colorectal Cancer"
2020-02-03,VBL Therapeutics to Present at the BIO CEO & Investor Conference
2020-01-27,Will VBL Continue to Surge Higher?
2020-01-20,We're Hopeful That Vascular Biogenics (NASDAQ:VBLT) Will Use Its Cash Wisely
2020-01-08,VBL Therapeutics Announces Publication of Phase 2 and Phase 3 Data of VB-111 in Recurrent Glioblastoma Supporting Continued Development in Investigator-Sponsored Study
2019-11-28,Should You Sell Vascular Biogenics Ltd. (VBLT)?
2019-11-21,VBL Therapeutics to Present Data on New Investigator-Sponsored Phase 2 Trial of VB-111 in Recurrent Glioblastoma at the 2019 Society for Neuro-Oncology Annual Meeting
2019-11-14,"Vascular Biogenics (VBLT) Reports Q3 Loss, Lags Revenue Estimates"
2019-11-14,VBL Therapeutics Announces Third Quarter 2019 Financial Results
2019-11-07,Vascular Biogenics (VBLT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
2019-11-06,VBL Therapeutics Announces New IND for an Investigator-Sponsored Phase 2 Trial of VB-111 in Recurrent Glioblastoma
2019-10-31,VBL Therapeutics to Report Third Quarter 2019 Financial Results on November 14
2019-10-03,"Easy Come, Easy Go: How Vascular Biogenics (NASDAQ:VBLT) Shareholders Got Unlucky And Saw 80% Of Their Cash Evaporate"
2019-08-13,"Vascular Biogenics (VBLT) Reports Q2 Loss, Misses Revenue Estimates"
2019-08-13,VBL Therapeutics Announces Second Quarter 2019 Financial Results
2019-08-13,Vascular Biogenics Ltd. to Host Earnings Call
2019-08-06,Vascular Biogenics (VBLT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
2019-08-05,VBL Therapeutics to Report Second Quarter 2019 Financial Results on August 13
2019-07-31,Do Insiders Own Shares In Vascular Biogenics Ltd. (NASDAQ:VBLT)?
2019-07-22,VBL Therapeutics Announces Modiin Production Facility Received a GMP Compliance Certificate Following EU QP Audit
2019-06-04,"VBL Therapeutics to Provide Additional Details on the New VB-111 Data Presented Earlier This Week at ASCO, in a Presentation at the 2019 BIO International Convention Today"
2019-06-03,VBL Final Phase 1/2 Study Results Presented at ASCO Demonstrate VB-111 Dose Dependent Increase in Overall Survival and 58% CA-125 Response Rate in Platinum-Resistant Ovarian Cancer
2019-06-03,Radiographic Analysis of VB-111 Phase 2 and 3 Clinical Trials in Recurrent Glioblastoma Shows Survival Benefit Associated with Objective Responses and Distinct Signature of VB-111 Activity
2019-05-23,VBL Therapeutics Announces Presentations at the 2019 ASCO Annual Meeting and the BIO International Convention
2019-05-16,Edited Transcript of VBLT earnings conference call or presentation 15-May-19 12:30pm GMT
2019-05-15,"Vascular Biogenics (VBLT) Reports Q1 Loss, Misses Revenue Estimates"
2019-05-15,Vascular Biogenics: 1Q Earnings Snapshot
2019-05-15,VBL Therapeutics Announces First Quarter 2019 Financial Results
2019-05-14,Vascular Biogen Expected to Lose 12 Cents a Share
2019-05-08,Will Vascular Biogenics (VBLT) Report Negative Earnings Next Week? What You Should Know
2019-05-06,VBL Therapeutics to Report First Quarter 2019 Financial Results on May 15
2019-04-04,Those Who Purchased Vascular Biogenics (NASDAQ:VBLT) Shares Three Years Ago Have A 54% Loss To Show For It
2019-03-29,Edited Transcript of VBLT earnings conference call or presentation 28-Mar-19 12:30pm GMT
2019-03-28,"Vascular Biogenics (VBLT) Reports Q4 Loss, Misses Revenue Estimates"
2019-03-28,"The Daily Biotech Pulse: Blueprint Medicine Expedites Clinical Programs, Eyepoint Offering, Precision Biosciences IPO"
2019-03-28,"VBL Therapeutics Announces Year Ended December 31, 2018 Financial Results and Provides Corporate Update"
2019-03-25,VBL Therapeutics to Present at Upcoming Conferences in April
2019-03-21,Analysts Estimate Vascular Biogenics (VBLT) to Report a Decline in Earnings: What to Look Out for
2019-03-19,VBL Presents New Data on Potential of VB-111 to Stimulate the Immune System and Drive Immune Cells to Infiltrate Tumor Microenvironment
2019-03-14,Earnings Preview: Vascular Biogenics (VBLT) Q4 Earnings Expected to Decline
